QUANTITATIVE ESTIMATION OF MISFOLDED TNFR2:Fc Russian patent published in 2019 - IPC C07K14/715 C07K1/16 

Abstract RU 2698671 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to the field of biotechnology. Described is a group of inventions involving a method of determining TNFR2:Fc with a disulphide bond Cys78-Cys88 in sample containing TNFR2:Fc with disulphide bonds Cys74-Cys88/Cys78-Cys96 and TNFR2:Fc with disulphide bond Cys78-Cys88, method of purifying TNFR2: Fc with disulphide bonds Cys74-Cys88/ Cys78-Cys96, method of producing and purifying TNFR2:Fc with disulphide Cys bonds74-Cys88/Cys78-Cys96 and TNFR2:Fc with disulphide bond Cys78-Cys88 and a composition of TNFR2:Fc for treating a disease selected from ankylosing spondylitis, juvenile rheumatoid arthritis, psoriasis, psoriatic arthritis and rheumatoid arthritis. In one embodiment, the method of producing and purifying TNFR2:Fc involves a step for preparing a composition containing TNFR2:Fc with disulphide Cys74-Cys88/Cys78-Cys96 and TNFR2:Fc with disulphide bond Cys78-Cys88.

EFFECT: invention extends the range of methods for determining and purifying TNFR2:Fc in a sample.

15 cl, 7 dwg, 7 tbl, 4 ex

Similar patents RU2698671C2

Title Year Author Number
VERSIONS OF PERTUZUMAB AND THEIR ANALYTICAL CHARACTERISTICS 2014
  • Gennaro Lynn A.
  • Kao Yung-Hsiang
  • Zhang Yonghua
RU2737727C2
HETERODIMERIC BISPECIFIC ANTIBODY AGAINST TNFα/AGAINST IL-17A, SIMILAR BY STRUCTURE TO NATURAL ANTIBODY, AND ITS PRODUCTION METHOD 2019
  • Liu Jiawang
  • Yang Yaping
  • Song Nanmeng
  • Xiao Wenchu
  • Chung Chulwoong
  • Kim Maengsup
RU2781816C1
VERSIONS AND ISOFORMS OF ANTIBODIES WITH REDUCED BIOLOGICAL ACTIVITY 2018
  • Khosoguti Kensaku
  • Kuvayama Maki
  • Sejda Tifumi
  • Vatanabe Esuke
  • Tanaka Nobuyuki
  • Sajto Satosi
  • Fukuda Masakadzu
RU2813990C2
METHODS AND COMPOSITIONS INCLUDING PURIFIED RECOMBINANT POLYPEPTIDES 2014
  • Yu Eks. Kristofer
  • Kadkhodayan Fisher Saloumej
  • Fisher Syuzan S.
  • Love Dzhon
  • Naim Atia
  • Sanchez Ailen M.
  • Teske Kristofer A.
  • Vanderlaan Martin
  • Amurao Annamari
  • Franklin Dzhejme
  • Vikta Korazon
RU2793783C1
ANTI-PD-L1/ANTI-4-1BB BISPECIFIC ANTIBODY IN HETERODIMERIC FORM, SIMILAR IN STRUCTURE TO NATURAL ANTIBODY, AND PRODUCTION THEREOF 2022
  • Liu Jiawang
  • Yang Yaping
  • Zhao Siqi
  • Liu Yang
  • Song Nanmeng
  • Fan Fei
  • Su Kaixuan
  • Zhang Lanxin
  • Wang Jing
  • Xu Jiangcheng
  • Lee Kyoung Woo
RU2825838C1
BIOPHARMACEUTICAL COMPOSITIONS AND METHODS RELATED THERETO 2020
  • Kranz James K.
  • Molloy Michael Joseph
  • Rinella, Jr. Joseph V.
  • Schmidt Elizabeth Rae
  • Schuessler Hillary Amber
  • Shah Tejash
RU2824761C2
PROTEIN COMPOSITIONS AGAINST VEGF AND METHODS FOR THEIR PRODUCTION 2020
  • Franklin, Matthew
RU2795973C1
Fc FUSION HIGH AFFINITY IgE RECEPTOR α-CHAIN 2016
  • Sakamoto, Takashi
  • Inada, Yoichi
  • Yokoyama, Kazumasa
RU2715606C2
CHIMERIC PROTEIN COMPOSED OF AN NGF ANTAGONIST DOMAIN AND A TNFΑ ANTAGONIST DOMAIN 2015
  • Schofield Darren
  • Sleeman Matthew Alexander
  • Chessell Iain Patrick
  • Hatcher Jonathan
  • Lowe David
RU2788122C2
PROTEIN COMPOSITIONS AGAINST VEGF AND METHODS FOR THEIR PREPARATION 2020
  • Tustian, Andrew
  • Vartak, Ankit
  • Daly, Thomas
  • Pyles, Erica
  • Palackal, Nisha
RU2788949C1

RU 2 698 671 C2

Authors

Rupprechter, Alfred

Fuchs, Michael

Lamanna, William

Holzmann, Johann

Posch, Christoph

Toll, Hansjoerg

Mayer, Robert

Dates

2019-08-28Published

2015-07-17Filed